Cationic peptides: effectors in innate immunity and novel antimicrobials.
about
The Neisseria meningitidis capsule is important for intracellular survival in human cellsAntimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal IndustryInsights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agentsCurrent and potential applications of host-defense peptides and proteins in urologyFunctional characterization of a melittin analog containing a non-natural tryptophan analogStructures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micellesEurocin, a New Fungal Defensin: STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTIONEvidence for Phenylalanine Zipper-Mediated Dimerization in the X-ray Crystal Structure of a Magainin 2 AnalogueSequence context induced antimicrobial activity: insight into lipopolysaccharide permeabilizationAntimicrobial Peptides Targeting Gram-Positive BacteriaQSAR modeling: where have you been? Where are you going to?Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosisComputational prediction of the optimal oligomeric state for membrane-inserted β-barrels of protegrin-1 and related mutants.Implicit Membrane Investigation of the Stability of Antimicrobial Peptide β-Barrels and Arcs.Biological and immunotoxicity evaluation of antimicrobial peptide-loaded coatings using a layer-by-layer process on titanium.Single molecule resolution of the antimicrobial action of quantum dot-labeled sushi peptide on live bacteria.Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?Cationic antimicrobial peptide resistance in Neisseria meningitidis.Successful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays.Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.Structure of the antimicrobial, cationic hexapeptide cyclo(RRWWRF) and its analogues in solution and bound to detergent micelles.Proline conformation-dependent antimicrobial activity of a proline-rich histone h1 N-terminal Peptide fragment isolated from the skin mucus of Atlantic salmon.High-throughput generation of small antibacterial peptides with improved activity.High-throughput and facile assay of antimicrobial peptides using pH-controlled fluorescence resonance energy transferHow to address CPP and AMP translocation? Methods to detect and quantify peptide internalization in vitro and in vivo (Review).Analysis and prediction of antibacterial peptides.Synergistic antibacterial and anti-inflammatory activity of temporin A and modified temporin B in vivoAntiBP2: improved version of antibacterial peptide predictionDifferential activity of innate defense antimicrobial peptides against Nocardia species.Indolicidin binding induces thinning of a lipid bilayerEvaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.Investigation into the antimicrobial action and mechanism of a novel endogenous peptide β-casein 197 from human milkAntimicrobial activity of murine lung cells against Staphylococcus aureus is increased in vitro and in vivo after elafin gene transfer.Assessment of anti-plasmodial activity of non-hemolytic, non-immunogenic, non-toxic antimicrobial peptides (AMPs LR14) produced by Lactobacillus plantarum LR/14.Determination of the spatiotemporal dependence of Pseudomonas aeruginosa biofilm viability after treatment with NLC-colistin.In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections.In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.Membrane binding of an acyl-lactoferricin B antimicrobial peptide from solid-state NMR experiments and molecular dynamics simulations.Antimicrobial peptides in toroidal and cylindrical pores.Antimicrobial peptides bind more strongly to membrane pores
P2860
Q24684877-E561A8B5-47F5-4BCA-AD96-3A51F259F0ADQ26751499-A20E6AA9-D55E-4E91-A7CA-FEA1A2F2C0E3Q26991996-CB4D35D9-1C9A-4D0F-8523-C6D137766FF5Q27027719-FC807D86-A50C-4BE0-9CD1-975E7AA317A0Q27339416-5C9C33B3-F22C-4BA3-A24D-147069437C76Q27652293-C05A763B-8900-43B3-93BA-7B8249896671Q27674703-36579B95-8A33-4ECD-B651-320A120CCDA2Q27680196-40F9B53F-6B81-45E8-97EC-CA3881814C7AQ27690024-27CFB4BF-62EE-4D61-9F21-416071C78E89Q28077888-0C01629E-0C57-4D6C-937D-7C0D6F6C1AC6Q28222668-AFD36158-E092-455E-8594-ABA297D669A0Q28475562-95785D71-7603-4E92-8283-62C2BACC275AQ30152643-C1C6BF82-0F9F-46AD-B6EF-719CEF6CF2EEQ30153294-B24A1FE8-47E4-4758-8E32-609719888097Q30397773-9946882F-113B-4BC7-B8A3-018AEA402AE8Q30487785-31717B48-4B9A-4B99-A497-0AE69AC3C1B6Q30564789-7D9E7DBE-2A5E-4661-9DA6-8AEBD40F602AQ30857151-4E6969EE-7D96-4804-A1CB-5F8AD25234A5Q30937880-39EF40F1-57BA-4C9F-94D8-139DD4C1C831Q30977526-6DB59BF2-4720-4009-8155-859230E4321DQ30997917-5AD790AE-34B8-45AF-9258-9A9BBBA58630Q33215847-37C1A9F3-442F-49CC-89B9-58392AEA021DQ33220258-B87AD58D-AD9E-477D-BBBE-A60FE9FEB0AFQ33258645-1F4730A9-408F-4CE1-B790-2810618C19EDQ33285497-9487DC15-A55E-472C-8D4A-8E24ACE65E42Q33291458-21B4188E-B813-45F5-B6EF-E52BB7691E4FQ33507093-88033C77-1DF9-4D65-8603-E5FD7362FDABQ33528189-85A53D80-BBFF-4DC6-B90A-BD9C13061152Q33533652-1DF9EE73-CF0B-4D68-9719-A11F8DADBACBQ33561547-5BE2459C-7BE5-4241-813C-1F69ED4F96B1Q33613788-B718B5B5-86F8-4C6E-BB14-E7EFE427EC4EQ33770020-52AF41E4-8435-495F-B561-1DE55A32F88AQ33788207-50D5165D-9262-4DA4-B81B-ACCDB65FAE6BQ33804744-9210533F-7FEB-4E20-8374-F60DC9B9BEB2Q33812561-6F3D7D4B-A555-4F41-981D-B67D3D4D869EQ33836677-8156232C-607A-4C3E-B468-D0567A2A15F3Q33857777-78A178B6-AEC5-43C7-8792-3B49B5A976DDQ33866571-B364F43D-1F68-44C6-91CD-A4371C378F84Q33912437-0EFC38AC-B721-438A-BA6E-DFD4A317531FQ33912494-007A9FCB-6680-4605-867A-F66DFC405CE4
P2860
Cationic peptides: effectors in innate immunity and novel antimicrobials.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@ast
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@en
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@nl
type
label
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@ast
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@en
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@nl
prefLabel
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@ast
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@en
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@nl
P1476
Cationic peptides: effectors in innate immunity and novel antimicrobials.
@en
P2093
R E Hancock
P304
P356
10.1016/S1473-3099(01)00092-5
P577
2001-10-01T00:00:00Z